ReviewFrontiers in physiology2026
T-cadherin as a potential novel regulator of intestinal inflammation and fibrosis.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
T-cadherin (T-cad) is a non-canonical member of the cadherin superfamily with a distinguished structure of its glycosylphosphatidylinositol (GPI) anchor instead of transmembrane and cytoplasmic domains. This lends unique properties to and equips T-cad with dynamic mobility within the plasma membrane and extensive lateral interactions with signaling partners. Beyond its role as an adhesion molecule forming homophilic interactions, T-cad functions as a receptor for adiponectin and low-density lipoprotein (LDL), therefore playing an important role in regulating cellular processes such as proliferation, differentiation, and migration. These properties underscore its critical involvement in physiological and pathological processes, including central nervous system development, cancer progression, and cardiovascular disease. However, the role of T-cad in intestinal inflammation, injury, and fibrosis remains underexplored. This review highlights the structural and functional characteristics of T-cad, its binding partners, its expression and functions in various types of cells, tissues and organs, and its roles in health and disease. This review also speculates on its potential involvement in intestinal inflammation, particularly in stricturing Crohn's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.